ACCO Brands Corp (NYSE:ACCO): Executive VP and CFO Neal V. Fenwick Bought 15,000 Shares
Executive VP and CFO of ACCO Brands Corp (NYSE:ACCO) Neal V. Fenwick bought 15,000 shares on 06/06/2013 at an average price of $6.63.
ACCO Brands Corporation was formerly known as ACCO World Corporation. ACCO Brands Corp has a market cap of $769.5 million; its shares were traded at around $7.01 with a P/E ratio of 6.18 and P/S ratio of 0.43.
On April 26, 2013, ACCO Brands Corporation reported its first quarter results for the period ended March 31, 2013. Net sales increased 22% to $352.0 million, compared to $288.9 million in the prior-year quarter, due to the merger with MeadWestvaco's Consumer & Office Products business (Mead C&OP). Loss from continuing operations was $8.9 million, or $0.08 per share, compared to a loss of $17.3 million, or $0.31 per share, in the prior-year quarter. Adjusted loss from continuing operations was $7.9 million, or $0.07 per share, excluding $11.4 million of pre-tax charges primarily for restructuring and IT integration costs and using a normalized tax rate of 35%. This compared to an adjusted loss of $3.0 million, or $0.05 per share, excluding $9.1 million of pre-tax charges primarily for restructuring and transaction-related costs and using a normalized tax rate of 30%, in the prior-year quarter.
President and COO Boris Elisman bought 2,750 shares of ACCO stock on 02/15/2013 at the average price of $8.1. Boris Elisman owns at least 22,136 shares after this. The price of the stock has decreased by 13.46% since.
Summer Infant Inc. (NASDAQ:SUMR): CFO Paul Francese Bought 10,000 Shares
CFO of Summer Infant Inc. (NASDAQ:SUMR) Paul Francese bought 10,000 shares on 05/30/2013 at an average price of $3.17.
Summer Infant Inc. was incorporated in Delaware. The company changed its name to Summer Infant, Inc. Summer Infant Inc. has a market cap of $61.5 million; its shares were traded at around $3.43 with a P/E ratio of 89.30 and P/S ratio of 0.25.
On May 13, 2013, Summer Infant Inc. announced financial results for the first quarter ended March 31, 2013. Net revenues for the three months ended March 31, 2013 decreased 6% to $59.1 million from $63.0 million for the three months ended March 31, 2012. The decrease in revenue was primarily driven by sales of discontinued non-profitable and low margin product SKUs throughout all product categories, as well as phasing out of licensing arrangements.
CFO Paul Francese bought 10,000 shares of SUMR stock on 05/30/2013 at the average price of $3.17. Paul Francese owns at least 30,000 shares after this. The price of the stock has increased by 8.2% since.
Coronado Biosciences Inc. (CNDO): CFO Lucy Lu Bought 4,979 Shares
CFO of Coronado Biosciences Inc. (CNDO) Lucy Lu bought 4,979 shares on 05/31/2013 at an average price of $3.88.
Coronado Biosciences Inc. is a biopharmaceutical company, engaged in the development of novel immunotherapy agents for cancer and inflammatory diseases. Coronado Biosciences Inchas a market cap of $248.8 million; its shares were traded at around $8.65 .
On May 8, 2013, Coronado Biosciences Inc. its financial results for the first quarter ended. Coronado reported a net loss of $8.9 million, or $0.35 per share, for the first quarter of 2013 compared to a net loss of $6.6 million, or $0.35 per share, for the first quarter of 2012.
Executive VP and COO Noah D. Beerman bought 5,000 shares of CNDO stock on 05/31/2013 at the average price of $3.88. Noah D. Beerman owns at least 15,000 shares after this.
For the complete list of stocks that were bought by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.